| 摘要 |
The invention relates to compositions, kits, and methods for cancer prophylaxis and therapy using recombinant MVA viruses encoding tumor-associated antigens, such as PSA and PAP. The recombinant MVA viruses can induce B- and T-cell responses. The recombinant MVA viruses can be administered prior to, at the same time as, or after a taxane. |
| 申请人 |
BN IMMUNOTHERAPEUTICS INC.;DELCAYRE, ALAIN;LAUS, REINER;MANDL, STEFANIE;ROUNTREE, RYAN, BLAIR;LEGRAND, FATEMA |
发明人 |
DELCAYRE, ALAIN;LAUS, REINER;MANDL, STEFANIE;ROUNTREE, RYAN, BLAIR;LEGRAND, FATEMA |
